The Wall Street Journal's obituary for Susan L. Solomon. (Image: CWR)
Susan L. Solomon died on September 8th after a battle with ovarian cancer. You probably wont know her name. I didnt.
But something in her Wall Street Journal obituary stirred memories of old and riveting debates.
When she was 18, Solomon married the drummer for the Sixties band Country Joe and the Fish, who played Woodstock. But that is not the story.
After divorcing the drummer, she went to law school, became a big wheel at the Sony Corporation and other companies, and ended up founding a charity dedicated to embryonic stem cell research, eventually raising almost half a billion dollars for that purpose.
Susan Solomon placed herself in the middle of a national debate over embryonic stem cell research.
You may remember the emotional and often fractious debate about embryonic stem cells. It roiled our political culture back during the Bush administration. For instance, practically every speaker at the 2004 Democratic National Convention that nominated Catholic John Kerry spoke about the desperate need for treatments and cures promised from embryonic stem cells. For example, Ron Reagan, the youngest son of Ronald and Nancy Reagan, focused his speech on embryonic stem cell research, concluding: Whatever else you do come Nov. 2, I urge you, please, cast a vote for embryonic stem cell research.
Anyone with moral qualms about killing human embryos for their body parts, that is, stem cells, was called anti-science. That may have been when that epithet was first coined.
Advocates of embryo-destructive research made certain rather outlandish claims.
In 2006, my wife Cathy and I were invited to run the final days of a statewide referendum on human cloning in Missouri. Proposed as an addition to the Missouri Constitution, Amendment 2 purported to ensure that Missouri patients would have access to any therapies and cures and allow Missouri researchers to conduct any research permitted under federal law. It also called for the banning of human cloning or attempted cloning.
The embryonic stem cell debate was then and is now replete with massive deceptions. In this case, that there is a difference between reproductive cloning and therapeutic cloning. Reproductive cloning was, they said, the deliberate creation of embryos that would be allowed to grow into toddlers. On the other hand, therapeutic cloning was acceptable because it created a human embryo and then allowed for her destruction to get at her stem cells.
And then there were the promises of treatments and cures. The primary talking point of the embryo-destruction crowd was there were a plethora of treatments and cures if only we could get at the stem cells of these tiny human beings.
Embryonic stem cells are pluripotent, that is, they have not yet become specific organs and can therefore become almost anything in the human body. This means they can be used to cure parts of the body that are damaged or diseased. In the Wall Street Journal obit of Solomon, it highlights that she helped raise more than $400 million for stem-cell research aimed at curing such diseases as cancer, diabetes and Parkinsons. Micheal J. Fox told members of Congress that Embryonic stem cell research holds enormous promise. Others claimed it would cure Alzheimers.
So, what is the state of stem cell research?
Well, first, there have been heroic efforts to obtain pluripotent cells without killing the human embryo. This resulted from George Bushs 2006 decision to end federal funding for the creation of new cell lines from the destruction of embryos. It forced scientists who wanted government funding to get creative. The use of adult stem cells grew from that, as did the development of something called induced pluripotent stem cells, where adult stem cells are coaxed into pluripotency. A Japanese doctor won the Nobel Prize for this in 2006.
While adult stem cells have been effective in treating many disorders, and this has been a Godsend for some, those cells are not pluripotent; that is, they cannot turn into anything other than what they are.
Induced pluripotent stem cells seem not to have taken off as first hoped. According to a 2018 article at Nature.com, The number of ES-cell publications grew rapidly after 2006 and has held pace, at about 2,000 per year since 2012.
The problem with embryonic stem cells is they are something of a wild child. They tend to die when you work with them or are prone to creating tumors. To date, there appears to have been only one person cured of anything using embryonic stem cells, a man who seems to no longer need insulin to treat his diabetes. We shall see if this lasts.
Most papers you find online about stem cell research are about making the cells easier to work with. Some tests are happening on actual patients. They think macular degeneration is a possible candidate for treatment with embryonic stem cells. But for the most part, researchers are trying to find ways to create new colonies from existing lines.
In the meantime, the scientists keep making promises, and the deceptions keep coming. For example, the website of the New York Stem Cell Foundation a foundation which Susan Solomon co-founded defines embryonic stem cells as pluripotent stem cells that come from blastocysts small clumps of five-to-seven-day-old embryo cells left over from in vitro fertilization treatments that would otherwise be discarded.
The good news is that they must keep the deception alive in order to proceed. Note they must claim embryonic stem cells only come from discarded embryos from IVF treatments. Of course, this does not change the monstrousness of their experimentations, but at least they feel they must keep the deception alive.
In the Wall Street Journal obit, Solomon is quoted as saying, Im really comfortable asking dumb questions.
Well, heres one. After killing only God knows how many thousands of little human beings and spending hundreds of millions of dollars that could have been spent in other ways, where are all those treatments and cures that were promised twenty years ago?
If you value the news and views Catholic World Report provides, please consider donating to support our efforts. Your contribution will help us continue to make CWR available to all readers worldwide for free, without a subscription. Thank you for your generosity!
Click here for more information on donating to CWR. Click here to sign up for our newsletter.
See the rest here:
Questioning the wisdom of the late Susan Solomon Catholic World Report - Catholic World Report
- Accelerating stem cell research - The University of British Columbia - November 22nd, 2024
- ISSCR Guidelines for Stem Cell Research and Clinical ... - PubMed - October 18th, 2024
- Induced pluripotent stem cell-derived mesenchymal stem cells: whether ... - October 18th, 2024
- AIIMS Bathinda Makes Breakthrough in Stem Cell Therapy Research for Heart Ailments - Elets - October 15th, 2024
- Manufactured stem cells could help to treat blood cancers in the future - October 8th, 2024
- New Facility Will Expand UC Merced's Groundbreaking Stem Cell Research - University of California, Merced - October 2nd, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 26th, 2024
- Scientists in Madison studying synthetic materials with applications in stem cell research - Wisbusiness.com - September 26th, 2024
- OpRegen (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium -... - September 26th, 2024
- Stem Cell Therapy Research: Creative Biolabs Advances iPSC-Derived Macrophage Solutions - openPR - September 20th, 2024
- Stem Cell Research About Stem Cells - September 20th, 2024
- $34 million for research into stem cell therapies for osteoarthritis and other conditions - BioMelbourne Network - September 18th, 2024
- $55 million for stem cell therapies, data infrastructure and research into rheumatoid arthritis - Department of Health - September 10th, 2024
- Discoveries from human stem cell research in space that are relevant to advancing cellular therapies on Earth - Nature.com - August 24th, 2024
- Stem Cell Therapy Market is expected to generate a revenue of USD 31.41 Billion by 2030, Globally, at 13.95% CAGR: Verified Market Research -... - August 16th, 2024
- Stem Cell Therapy Market is expected to generate a revenue of USD 31.41 Billion by 2030, Globally, at 13.95% CAGR: Verified Market Research - PR... - August 12th, 2024
- Advanced Parkinsons in a dish model accelerates research Harvard ... - August 10th, 2024
- Understanding Stem Cell Research | UCLA BSCRC - August 6th, 2024
- TREEFROG THERAPEUTICS PARTICIPATES IN AN INNOVATION SHOWCASE & POSTER SESSION AT THE INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH (ISSCR) ANNUAL... - July 12th, 2024
- Familiar face to take over as CEO of California's stem cell research funding agency - The Business Journals - July 12th, 2024
- Factor Bioscience to Deliver Six Presentations at the International Society for Stem Cell Research (ISSCR) 2024 Annual Meeting - The Malaysian Reserve - July 12th, 2024
- Research harnesses machine learning and imaging to give insight into stem cell behavior - Medical Xpress - July 5th, 2024
- Stem Cell Research Uncovers Clues to Tissue Repair That Could Help Heal the Uterus and More - Yale School of Medicine - May 29th, 2024
- Theradaptive Secures Landmark Funding from Maryland Stem Cell Research Fund (MSCRF) to Support Human ... - PR Newswire - May 27th, 2024
- Unparalleled Research on Adipose Tissue-Derived Stem Cell Therapy Market With Current and Future Growth ... - openPR - May 15th, 2024
- 100 plus years of stem cell research20 years of ISSCR - PMC - March 26th, 2024
- Stem Cell Science and Human Research Studies Ahead of Cargo Arrival - NASA Blogs - February 18th, 2024
- Stem cell research project to launch into space - Fox Weather - January 24th, 2024
- Breakthrough in cancer research opening up stem cell therapy to more people. How you can get involved - 69News WFMZ-TV - January 20th, 2024
- Stem Cell Research Heading to the ISS on Axiom Mission 3 - ISS National Lab - January 18th, 2024
- No, Rep. Steve Scalise Didn't Vote Against Stem Cell Research From Which He Is Now Benefiting - The Dispatch - January 12th, 2024
- Applications are open for the Maryland Stem Cell Research Fund - Technical.ly - January 4th, 2024
- Global Stem Cell Therapy Market to Reach USD 928.6 Million by 2031: Says Allied Market Research - Yahoo Finance - November 19th, 2023
- Current state of stem cell-based therapies: an overview - PMC - November 3rd, 2023
- Dynamic Stem Cell Therapy Uncovers Research in Advance Regenrative Medicine - Yahoo Finance - November 3rd, 2023
- Research Fellow (Aging and Cancer Stem Cell Laboratory ... - Times Higher Education - October 15th, 2023
- Qkine Collaborates with the Cambridge Stem Cell Institute to Facilitate Same-Day Access to Key Research Products for Researchers at the Cambridge... - September 27th, 2023
- Stem cells: a comprehensive review of origins and emerging clinical ... - September 25th, 2023
- Stem Cell Research and Communicating Science | GBH - GBH News - September 20th, 2023
- Stem cell research reveals the earliest stages of a human life - SBS News - September 10th, 2023
- Stem Cell Therapy Market Size 2023 | Innovative Research Methodologies with Emerging Trends and Opportuni - Benzinga - September 10th, 2023
- Autologous Stem Cell and Non-Stem Cell Based Therapies Market Research, Current Trends, Key Industry Play - Benzinga - September 8th, 2023
- Stem Cell Therapy Market 2023 Business Statistics and Research ... - The Knox Student - August 28th, 2023
- Autologous Stem Cell Based Therapies Market Analysis, Research ... - Chatfield News-Record - July 19th, 2023
- Global Stem Cell Market Projected to Reach $14 Bn by 2028: Ken Research - Yahoo Finance - July 11th, 2023
- Theradaptive Awarded Manufacturing Assistance Grant by the Maryland Stem Cell Research Fund - Benzinga - July 10th, 2023
- Bionano Announces Presentation of OGM Utility Across Stem Cell Therapy Applications at the International Society for Stem Cell Research (ISSCR) Annual... - June 19th, 2023
- Sana Biotechnology Highlights Preclinical Data from Hypoimmune and Fusogen Platforms at the International Society for Stem Cell Research (ISSCR) 2023... - June 17th, 2023
- Induced Pluripotent Stem Cell (iPSC) Global Market Report 2023: Effective Research Programs Hold Key in Roll Out of Advanced iPSC Treatments - Yahoo... - June 17th, 2023
- Lung and heart stem cell research paves way for new COVID-19 treatments - Medical Xpress - June 14th, 2023
- Toxicology PhD student cultivating giant leaps in stem cell research ... - June 4th, 2023
- Harvard Stem Cell Institute (HSCI) - May 26th, 2023
- Findings may lead to improved insulin-secreting cells derived from stem ... - May 26th, 2023
- Cell Press: Stem Cell Reports - May 26th, 2023
- Stem cell research could enable blood to be made in other parts of the body - Medical Xpress - May 26th, 2023
- Construction of myocardial patch with mesenchymal stem cells and poly ... - May 22nd, 2023
- Cedars-Sinai to Send Stem Cells to the Space Station to Aid in the ... - May 22nd, 2023
- researchers expand human blood stem cells | Institute for Stem Cell ... - May 22nd, 2023
- A Look Inside Stem Cells Helps Create Personalized Regenerative ... - May 17th, 2023
- Exclusive Research Report on Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market to Witness Comp - openPR - May 17th, 2023
- The Future of Stem Cell Research: Master of Science in ... - The Daily | Case Western Reserve University - May 10th, 2023
- Exclusive Research Report on Stem Cell Therapy for Diabetes and ... - Digital Journal - May 9th, 2023
- Aging melanocyte stem cells and gray hair | National Institutes of ... - May 5th, 2023
- Mouse hair turns gray when certain stem cells get stuck - May 5th, 2023
- Science-First Skincare Company Michal Morrison Secures Exclusive World-Wide License of Proprietary STEM6 Molecule, Supported by Over 25 Years of... - May 5th, 2023
- BioCentriq and panCELLa execute research agreement to study stem cell-derived Natural Killer cell expansi - Benzinga - May 3rd, 2023
- Hair turning gray? Study finds a stem cell 'glitch' may be the cause - May 1st, 2023
- Elevai Labs Announces Research Grant Award and Partnership to Better Characterize the 'Payload' of ELEVAI's Stem Cell-derived Exosomes - Yahoo Finance - April 27th, 2023
- Why does hair turn gray? A new study says 'stuck' stem cells may ... - NPR - April 27th, 2023
- Study advances understanding of how melanocyte stem cells work to color ... - April 21st, 2023
- Stem cell research and therapy legislation to be replaced, says ... - Bahamas Tribune - April 21st, 2023
- Stem Cell Research (journal) - Wikipedia - April 21st, 2023
- Scientists Are About to Try to Create Stem Cells in Space - April 21st, 2023
- Stem Cell Research & Therapy | Articles - BioMed Central - April 16th, 2023
- Stem Cell Junk Yards Reveal a New Clue About Aging | WIRED - April 16th, 2023
- Global Stem Cells Market Research Report 2023: Implications - April 16th, 2023
- Stem cell research can help people with hard- | EurekAlert! - April 16th, 2023
- University Of Edinburgh's stem cell research gets funding boost - India Education Diary - April 14th, 2023
- Two major stem cell research projects supported with more than ... - University of California, Santa Cruz - April 8th, 2023
- Cancer detection predicts tumors before they form: discovery - March 29th, 2023
Recent Comments